General Information of Drug Off-Target (DOT) (ID: OTYOYP14)

DOT Name Carboxypeptidase N subunit 2 (CPN2)
Synonyms Carboxypeptidase N 83 kDa chain; Carboxypeptidase N large subunit; Carboxypeptidase N polypeptide 2; Carboxypeptidase N regulatory subunit
Gene Name CPN2
Related Disease
Neoplasm ( )
Coronary heart disease ( )
Leiomyoma ( )
Uterine fibroids ( )
Anorexia nervosa cachexia ( )
Obesity ( )
UniProt ID
CPN2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13855
Sequence
MLPGAWLLWTSLLLLARPAQPCPMGCDCFVQEVFCSDEELATVPLDIPPYTKNIIFVETS
FTTLETRAFGSNPNLTKVVFLNTQLCQFRPDAFGGLPRLEDLEVTGSSFLNLSTNIFSNL
TSLGKLTLNFNMLEALPEGLFQHLAALESLHLQGNQLQALPRRLFQPLTHLKTLNLAQNL
LAQLPEELFHPLTSLQTLKLSNNALSGLPQGVFGKLGSLQELFLDSNNISELPPQVFSQL
FCLERLWLQRNAITHLPLSIFASLGNLTFLSLQWNMLRVLPAGLFAHTPCLVGLSLTHNQ
LETVAEGTFAHLSNLRSLMLSYNAITHLPAGIFRDLEELVKLYLGSNNLTALHPALFQNL
SKLELLSLSKNQLTTLPEGIFDTNYNLFNLALHGNPWQCDCHLAYLFNWLQQYTDRLLNI
QTYCAGPAYLKGQVVPALNEKQLVCPVTRDHLGFQVTWPDESKAGGSWDLAVQERAARSQ
CTYSNPEGTVVLACDQAQCRWLNVQLSPQQGSLGLQYNASQEWDLRSSCGSLRLTVSIEA
RAAGP
Function The 83 kDa subunit binds and stabilizes the catalytic subunit at 37 degrees Celsius and keeps it in circulation. Under some circumstances it may be an allosteric modifier of the catalytic subunit.
Reactome Pathway
Regulation of Complement cascade (R-HSA-977606 )

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Biomarker [1]
Coronary heart disease DIS5OIP1 Strong Biomarker [2]
Leiomyoma DISLDDFN Strong Biomarker [3]
Uterine fibroids DISBZRMJ Strong Biomarker [3]
Anorexia nervosa cachexia DISFO5RQ moderate Altered Expression [4]
Obesity DIS47Y1K moderate Biomarker [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [5]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [6]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [7]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [8]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [9]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [11]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [12]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Carboxypeptidase N subunit 2 (CPN2). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation.Cell Metab. 2019 Aug 6;30(2):274-289.e5. doi: 10.1016/j.cmet.2019.04.004. Epub 2019 May 2.
2 Myocardial Injury Is Distinguished from Stable Angina by a Set of Candidate Plasma Biomarkers Identified Using iTRAQ/MRM-Based Approach.J Proteome Res. 2018 Jan 5;17(1):499-515. doi: 10.1021/acs.jproteome.7b00651. Epub 2017 Nov 7.
3 Expression of the energy substrate transporters in uterine fibroids.Prostaglandins Other Lipid Mediat. 2016 Mar;123:9-15. doi: 10.1016/j.prostaglandins.2016.02.002. Epub 2016 Feb 27.
4 Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.Cell Metab. 2019 Oct 1;30(4):754-767.e9. doi: 10.1016/j.cmet.2019.07.010. Epub 2019 Aug 15.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
7 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
8 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
9 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
10 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
11 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
12 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
13 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.